share_log

HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35

Benzinga ·  May 10 15:39

HC Wainwright & Co. analyst Patrick Trucchio maintains Mind Medicine (NASDAQ:MNMD) with a Buy and lowers the price target from $75 to $35.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment